SODIUM PHOSPHATES Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sodium Phosphates, and when can generic versions of Sodium Phosphates launch?
Sodium Phosphates is a drug marketed by Fresenius Kabi Usa and Hospira and is included in two NDAs.
The generic ingredient in SODIUM PHOSPHATES is sodium phosphate, dibasic, heptahydrate; sodium phosphate, monobasic, anhydrous. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium phosphate, dibasic, heptahydrate; sodium phosphate, monobasic, anhydrous profile page.
Summary for SODIUM PHOSPHATES
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in SODIUM PHOSPHATES? | SODIUM PHOSPHATES excipients list |
DailyMed Link: | SODIUM PHOSPHATES at DailyMed |
Pharmacology for SODIUM PHOSPHATES
Drug Class | Osmotic Laxative |
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Anatomical Therapeutic Chemical (ATC) Classes for SODIUM PHOSPHATES
US Patents and Regulatory Information for SODIUM PHOSPHATES
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius Kabi Usa | SODIUM PHOSPHATES | sodium phosphate, dibasic, heptahydrate; sodium phosphate, monobasic, anhydrous | INJECTABLE;INJECTION | 209997-001 | Mar 30, 2022 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Hospira | SODIUM PHOSPHATES IN PLASTIC CONTAINER | sodium phosphate, dibasic, heptahydrate; sodium phosphate, monobasic, anhydrous | INJECTABLE;INJECTION | 018892-001 | May 10, 1983 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |